表紙
市場調査レポート

世界のバイオテクノロジー部門における培地・血清・試薬市場:新興市場

Global Markets for Media, Sera and Reagents in Biotechnology -- Focus on Emerging Markets

発行 BCC Research 商品コード 238961
出版日 ページ情報 英文 185 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
世界のバイオテクノロジー部門における培地・血清・試薬市場:新興市場 Global Markets for Media, Sera and Reagents in Biotechnology -- Focus on Emerging Markets
出版日: 2012年04月26日 ページ情報: 英文 185 Pages
担当者のコメント
米国、欧州、アジア版につきましても別冊にて刊行されています。
概要

世界のバイオテクノロジー部門における培地・血清・試薬の市場は2009年に23億米ドル、2010年には25億米ドルを記録しました。また、2011年は推計でおよそ28億米ドルに達したと見られます。同市場は今後、8.8%の年平均成長率(CAGR)で拡大し、2016年には42億米ドルの規模に達すると予測されています。新興地域における細胞培養製品市場は、2009年に1億2870万米ドル、2010年には1億3480万米ドルに達しました。同市場は、2011年には1億4150万米ドルとなり、2016年には1億7830万米ドルとなることが予測されています。 また、新興地域の細胞培養培地市場は、2009年に5220万米ドル、2010年に5490万米ドルとなりました。同市場は、2011年には5790万米ドルを記録し、2016年には7450万米ドルに達する見通しです。

当レポートでは、世界のバイオテクノロジー部門における培地・血清・試薬市場の現状と見通しについて、特に新興市場を中心に調査分析しており、細胞および細胞培養の基礎、細胞培養の種類と概要、各種市場影響因子の分析、培地・血清・試薬の区分別の市場規模実績・予測(〜2016年)、主要企業の市場シェアや主要企業のプロファイルなどをまとめ、概略以下の構成でお届けします。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 概要

  • 定義
  • 経緯
  • 細胞培養のタイプ
  • 培養中の細胞の形態
  • 細胞培養の基本的システム
  • 細胞系・細胞下部・形質転換細胞系
  • 細胞培養への影響因子
  • 細胞培養の用途
  • 細胞培養中の問題
  • 細胞培養の基礎要件
  • 法規制上の側面
  • 生物学的製剤の申請承認
  • 管理上のアクション:生物学的製剤
  • 培地の主要製造業者
  • 新たな開発
  • 新たな開発:用途

第4章 世界市場

  • 培地
    • 市場収益
    • 市場シェア
    • 無血清培地と血清培地
    • 粉末培地と液体培地
    • 汎用培地と特殊培地
  • 血清
    • 市場収益
    • 市場シェア
    • ウシ血清またはウシ胎児血清
    • その他の血清
  • 試薬
    • 市場概要
    • 市場収益
    • 市場シェア
    • 生体応答調節剤
    • 細胞解離試薬
    • その他

第5章 新興市場

  • 培地
    • 市場概要
    • 無血清培地と血清培地
    • 粉末培地と液体培地
    • 汎用培地と特殊培地
  • 血清
    • 市場概要
    • 市場収益
  • 試薬
    • 市場概要
    • 市場収益
    • 生体応答調節剤
  • 市場におけるリーダー

第6章 エンドユーザー

  • 用途別の市場シェア
  • 調査区分
  • 製造区分
  • 委託区分
  • その他の区分

第7章 特許分析

  • 年別
  • 種類別
  • 企業別
  • 国別
  • 譲受人別

第8章 現況

  • 地域市場
  • 細胞培養市場の動向および課題

第9章 企業プロファイル

第10章 付録

図表

目次
Product Code: BIO098A

Abstract

REPORT HIGHLIGHTS

The global market for media, sera and reagents used in biotechnology was valued at $2.3 billion in 2009, $2.5 billion in 2010 and is estimated to have reached nearly $2.8 billion at the end of 2011. The market is expected to reach $4.2 billion by 2016, a compound annual growth rate (CAGR) of 8.8%.

The emerging markets for cell culture products totaled $128.7 million in 2009 and reached $134.8 million in 2010. This market is expected to increase from $141.5 million in 2011 to $178.3 million by 2016, at a CAGR of 4.7%.

Cell culture media sales in the emerging markets amounted to $52.2 million in 2009 and reached $54.9 million in 2010. Increasing at a CAGR of 5.2% the cell culture media market is expected to grow from $57.9 million in 2011 to $74.5 million by 2016.

image1

REPORT SCOPE

INTRODUCTION

STUDY OBJECTIVES

BCC's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for media, sera and the reagents used in biotechnology. The key objective is to present a comprehensive analysis of the current market and its future direction in the media, sera and biotechnology reagents markets as an important tool for the cell culture industry.

This report explores present and future strategies within the media and sera market, including reagents used in biotechnology. The improvisation of the market, the setbacks and the needs of the market are discussed in this report. The types of cell cultures and the products from cell culture technology are also presented in this report. The advantages and disadvantages for the use of various types of media are also covered in this report.

A detailed analysis of the cell culture industry structure has been conducted. This includes the biotechnology reagents, media and the sera used. Revenues are broken down by global region. Sales figures are estimated for the five-year period from 2011 through 2016.

Applications for the cell culture industry - media, sera and reagents used in biotechnology - are also discussed in the report, with an emphasis on the usage in the research, production and contract segments. The report also covers significant patents in each segment.

REASONS FOR DOING THIS STUDY

Demand for cell culture products, namely media, sera and reagents, is increasing, with the increasing demand for biopharmaceuticals. Cell culture, a crucial component of the life sciences industry, has witnessed major development during the past three decades. R&D spending, along with increasing competition, patent expiries, new technologies and an international marketplace are moving the cell culture process in a new direction. As cell culture technologies evolved, a number of disciplines such as cell biology, genetic engineering, protein chemistry, genomics and chemical engineering have been successfully incorporated into the cell culture field.

Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of the different types of media used in light of the new technologies, growing competition and changing customer needs.

INTENDED AUDIENCE

This study contributes to the areas of market growth in the cell culture industry from the point of view of manufacturers and users. Biotechnological companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals and research institutes will find this study to be of interest.

SCOPE OF THE STUDY

The scope of this study encompasses the biotechnology, pharmaceutical and medical markets. BCC analyzes each market and its applications by its need for development of new medications through cell culture techniques, the regulatory environment, technology involved, market projections and market share. Technological issues include the latest trends and developments.

METHODOLOGY

BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data was collected through interviews and correspondence with various analytical, chemical, pharmaceutical and biotechnical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of biopharmaceuticals, and pharmaceutical companies through their production, research and contract manufacturing/research lines. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, consulted newsletters, company literature, product literature and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources.

ABOUT THE AUTHOR

The study has been carried out by a team of professionals in the biotechnology industry. The project manager for this project is Shalini S. Dewan, who holds a Master's degree in Pharmaceutical Chemistry and has more than 14 years of industry experience. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are Reagents for Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; and Cancer Therapies: Technologies and Global Markets.

The lead consultant for this project was Dr. Kapil A. Setia, who holds a doctoral degree in the life sciences. She has a number of research publications to her credit.

Table of Contents

Chapter- 1: INTRODUCTION - Complimentary

  • STUDY OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • INTENDED AUDIENCE
  • SCOPE OF THE STUDY
  • METHODOLOGY
  • INFORMATION SOURCES
  • ABOUT THE AUTHOR
  • RELATED BCC RESEARCH REPORTS
  • BCC ONLINE SERVICES
  • DISCLAIMER

Chapter- 2: EXECUTIVE SUMMARY

  • Table Summary : GLOBAL REVENUES FROM MEDIA, SERA AND REAGENTS USED IN THE BIOTECHNOLOGY MARKET, THROUGH 2016
  • Figure Summary : GLOBAL REVENUES FROM MEDIA, SERA AND REAGENTS USED IN THE BIOTECHNOLOGY MARKET, 2009-2016

Chapter- 3: OVERVIEW

  • DEFINITIONS
  • HISTORY
  • TYPES OF CELL CULTURES
  • MORPHOLOGY OF CELLS IN CULTURE
  • BASIC SYSTEMS FOR CELL CULTURE
  • CELL LINE, CELL STRAIN AND TRANSFORMED CELL LINES
  • FACTORS AFFECTING CELL CULTURE
  • APPLICATIONS OF CELL CULTURE
  • PROBLEMS DURING CELL CULTURE
  • BASIC REQUIREMENTS OF CELL CULTURE
  • REGULATORY ASPECTS
  • APPROVALS OF BIOLOGICAL LICENSE APPLICATIONS
  • ADMINISTRATIVE ACTIONS: BIOLOGICS
  • LEADING MANUFACTURERS OF MEDIA
  • NEW DEVELOPMENTS
  • NEW DEVELOPMENTS IN APPLICATIONS
  • Table 24 : NEW DEVELOPMENTS IN APPLICATION OF CELL CULTURE

Chapter- 4: GLOBAL MARKETS

  • MEDIA
  • SERA
  • REAGENTS

Chapter- 5: EMERGING MARKETS/REST OF THE WORLD MARKET

  • MEDIA
  • SERA
  • REAGENTS
  • MARKET LEADERS IN THE EMERGING MARKETS

Chapter- 6: END USERS

  • MARKET SHARE OF APPLICATIONS
  • RESEARCH SEGMENT
  • PRODUCTION SEGMENT
  • CONTRACT SEGMENT
  • OTHERS SEGMENT

Chapter- 7: PATENT ANALYSIS

  • PATENTS BY YEAR
  • PATENTS BY TYPE
  • PATENTS BY COMPANY
  • PATENTS BY COUNTRY
  • PATENTS BY ASSIGNEE
  • Table 75 : U.S. PATENTS ISSUED FOR MEDIA, SERA AND REAGENTS USED IN BIOTECHNOLOGY BY TYPE OF END USER, 2007 TO OCT. 2011

Chapter- 8: THE CURRENT SITUATION

  • REGIONAL MARKETS
  • TRENDS AND ISSUES IN THE CELL CULTURE MARKET

Chapter- 9: COMPANY PROFILES

  • ADVANCED BIOTECHNOLOGIES INC.
  • AFFYMETRIX
  • AMRESCO LLC
  • ATHENA ENVIRONMENTAL SCIENCES INC.
  • ATLANTA BIOLOGICALS INC.
  • BD BIOSCIENCES
  • BIORECLAMATION INC.
  • BOVOGEN BIOLOGICALS PTY. LTD.
  • CELL APPLICATIONS INC.
  • CELL CULTURE TECHNOLOGIES GMBH
  • CLONTECH LABORATORIES INC.
  • EQUITECH-BIO INC.
  • GEMINI BIO-PRODUCTS
  • GENEX INDIA BIOSCIENCES PVT. LTD.
  • HIMEDIA LABORATORIES
  • INVITROGEN CORP.
  • IRVINE SCIENTIFIC
  • J R SCIENTIFIC INC.
  • LONZA
  • MEDIATECH INC.
  • MEDOX BIOTECH INDIA PVT. LTD.
  • MILLIPORE CORP.
  • MP BIOMEDICALS
  • PAA LABORATORIES
  • PEPROTECH INC.
  • PROMOCELL GMBH
  • QUALITY BIOLOGICAL INC.
  • R&D SYSTEMS
  • ROCHE APPLIED SCIENCES
  • SERA LABORATORIES INTERNATIONAL LTD.
  • SERACARE LIFE SCIENCES INC.
  • SIGMA-ALDRICH
  • STEMCELL TECHNOLOGIES
  • STEMCELLS INC.
  • THERMO FISHER SCIENTIFIC INC.
  • TICO EUROPE
  • VALLEY BIOMEDICAL PRODUCTS AND SERVICES INC.

Chapter- 10: APPENDIX: ABBREVIATIONS

List of Tables

  • Summary Table : GLOBAL REVENUES FROM MEDIA, SERA AND REAGENTS USED IN THE BIOTECHNOLOGY MARKET, THROUGH 2016
  • Table 1 : HISTORICAL EVENTS IN CELL CULTURE DEVELOPMENT
  • Table 2 : ADVANTAGES AND DISADVANTAGES OF PRIMARY CELL CULTURE
  • Table 3 : ADVANTAGES AND DISADVANTAGES OF CONTINUOUS CELL CULTURE
  • Table 4 : ADHERENT CULTURE VS. SUSPENSION CULTURE
  • Table 5 : CULTURE MEDIA USED FOR THE PRODUCTION OF VACCINES
  • Table 6 : POTENTIAL SOURCES OF CELL CULTURE ADDITIVES
  • Table 7 : RECOMBINANT THROMBOLYTIC AGENTS
  • Table 8 : RECOMBINANT COAGULATION FACTOR
  • Table 9 : THE ROLES OF DIFFERENT INORGANIC NUTRIENTS
  • Table 10 : COMMONLY USED ANTIBIOTICS IN CELL CULTURES
  • Table 11 : ADVANTAGES AND DISADVANTAGES OF SERUM-CONTAINING MEDIA
  • Table 12 : ADVANTAGES AND DISADVANTAGES OF SERUM-FREE MEDIA
  • Table 13 : NORMAL RANGE OF CONCENTRATION OF SERUM CONSTITUENTS
  • Table 14 : APPROVALS OF BIOLOGICAL LICENSE APPLICATIONS, 2010 TO AUG. 2011
  • Table 15 : ADMINISTRATIVE ACTIONS: BIOLOGICS, 2007 TO AUG. 2011
  • Table 16 : PRODUCT RECALLS, 2007 TO AUG. 2011
  • Table 17 : LEADING MANUFACTURERS OF MEDIA
  • Table 18 : LEADING MANUFACTURERS OF SERA
  • Table 19 : LEADING MANUFACTURERS OF BIOLOGIC RESPONSE MODIFIERS
  • Table 20 : LEADING MANUFACTURERS OF CELL DISSOCIATION REAGENTS
  • Table 21 : LEADING MANUFACTURERS OF ANTIBIOTICS AND ANTIMYCOTICS USED IN CELL CULTURE
  • Table 22 : LEADING MANUFACTURERS OF OTHER REAGENTS
  • Table 23 : NEW DEVELOPMENTS IN THE CELL CULTURE INDUSTRY SINCE 2008
  • Table 24 : NEW DEVELOPMENTS IN APPLICATION OF CELL CULTURE
  • Table 25 : GLOBAL MARKET FOR CELL CULTURE PRODUCTS, THROUGH 2016
  • Table 26 : GLOBAL MARKET FOR MEDIA USED IN BIOTECHNOLOGY BY REGION, THROUGH 2016
  • Table 27 : GLOBAL BIOTECHNOLOGY MEDIA MARKET SHARES BY REGION, 2010
  • Table 28 : GLOBAL MARKET FOR SERUM-FREE MEDIA BY REGION, THROUGH 2016
  • Table 29 : GLOBAL MARKET FOR SERUM-REQUIRING MEDIA BY REGION, THROUGH 2016
  • Table 30 : GLOBAL MARKET FOR POWDERED MEDIA, THROUGH 2016
  • Table 31 : GLOBAL MARKET FOR LIQUID MEDIA BY REGION, THROUGH 2016
  • Table 32 : GLOBAL MARKET FOR CLASSICAL MEDIA BY REGION, THROUGH 2016
  • Table 33 : GLOBAL MARKET FOR SPECIALTY MEDIA BY REGION, THROUGH 2016
  • Table 34 : GLOBAL MARKET FOR SERA BY REGION, THROUGH 2016
  • Table 35 : GLOBAL SERA MARKET SHARES BY REGION, 2010
  • Table 36 : GLOBAL MARKET FOR BOVINE SERA BY REGION, THROUGH 2016
  • Table 37 : GLOBAL MARKET FOR OTHER SERA BY REGION, THROUGH 2016
  • Table 38 : GLOBAL MARKET FOR CELL CULTURE REAGENTS BY REGION, THROUGH 2016
  • Table 39 : GLOBAL CELL CULTURE REAGENT MARKET SHARES BY REGION, 2010
  • Table 40 : GLOBAL MARKET FOR BIOLOGICAL RESPONSE MODIFIERS BY REGION, THROUGH 2016
  • Table 41 : GLOBAL MARKET FOR GROWTH FACTORS BY REGION, THROUGH 2016
  • Table 42 : GLOBAL MARKET FOR CYTOKINES BY REGION, THROUGH 2016
  • Table 43 : GLOBAL MARKET FOR OTHER BIOLOGICAL RESPONSE MODIFIERS BY REGION, THROUGH 2016
  • Table 44 : GLOBAL MARKET FOR CELL DISSOCIATION REAGENTS BY REGION, THROUGH 2016
  • Table 45 : GLOBAL MARKET FOR OTHERS BY REGION, THROUGH 2016
  • Table 46 : EMERGING MARKETS FOR CELL CULTURE PRODUCTS, THROUGH 2016
  • Table 47 : EMERGING MARKETS FOR CELL CULTURE MEDIA, THROUGH 2016
  • Table 48 : EMERGING MARKETS FOR SERUM-REQUIRING AND SERUM-FREE MEDIA, THROUGH 2016
  • Table 49 : EMERGING MARKETS FOR POWDERED AND LIQUID MEDIA, THROUGH 2016
  • Table 50 : EMERGING MARKETS FOR CLASSICAL AND SPECIALTY MEDIA, THROUGH 2016
  • Table 51 : EMERGING MARKETS FOR BOVINE AND OTHER SERA, THROUGH 2016
  • Table 52 : EMERGING MARKETS FOR CELL CULTURE REAGENTS, THROUGH 2016
  • Table 53 : EMERGING MARKETS FOR BIOLOGICAL RESPONSE MODIFIERS, THROUGH 2016
  • Table 54 : MARKET SHARES OF SERUM FREE MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 55 : MARKET SHARES OF SERUM-CONTAINING MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 56 : MARKET SHARES OF POWDERED MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 57 : MARKET SHARES OF LIQUID MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 58 : MARKET SHARES OF CLASSICAL MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 59 : MARKET SHARES OF SPECIALTY MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 60 : MARKET SHARES OF BOVINE SERA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 61 : MARKET SHARES OF OTHER SERA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 62 : MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 63 : MARKET SHARES OF CELL DISSOCIATION REAGENTS IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 64 : MARKET SHARES OF OTHER REAGENTS IN THE EMERGING MARKETS BY COMPANY, 2010
  • Table 65 : GLOBAL MEDIA, SERA AND REAGENT MARKET SHARES BY END USER, 2010
  • Table 66 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE RESEARCH SEGMENT, THROUGH 2016
  • Table 67 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE PRODUCTION SEGMENT, THROUGH 2016
  • Table 68 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE CONTRACT SEGMENT, THROUGH 2016
  • Table 69 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE OTHERS SEGMENT, THROUGH 2016
  • Table 70 : NUMBER OF U.S. PATENTS ISSUED BY YEAR, 2007 TO OCT. 2011
  • Table 71 : PATENTS BY TYPE FOR MEDIA, SERA AND REAGENTS USED IN BIOTECHNOLOGY, 2007 - 2011
  • Table 72 : U.S. PATENTS ISSUED FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY BY COMPANY, 2007 TO OCT. 2011
  • Table 73 : U.S. PATENTS ISSUED FOR MEDIA, SERA AND REAGENTS USED IN BIOTECHNOLOGY BY COUNTRY, 2007 TO OCT. 2011
  • Table 74 : SHARES OF U.S. PATENTS ISSUED FOR MEDIA, SERA AND REAGENTS USED IN BIOTECHNOLOGY BY COUNTRY, 2007 - OCT. 2011
  • Table 75 : U.S. PATENTS ISSUED FOR MEDIA, SERA AND REAGENTS USED IN BIOTECHNOLOGY BY TYPE OF END USER, 2007 TO OCT. 2011
  • Table 76 : R&D BUDGETS OF TOP 10 COMPANIES IN 2009 AND 2010

List of Figures

  • Summary Figure : GLOBAL REVENUES FROM MEDIA, SERA AND REAGENTS USED IN THE BIOTECHNOLOGY MARKET, 2009-2016
  • Figure 1 : GLOBAL MARKET FOR CELL CULTURE PRODUCTS, 2009-2016
  • Figure 2 : GLOBAL MARKET FOR MEDIA USED IN BIOTECHNOLOGY BY REGION, 2009-2016
  • Figure 3 : GLOBAL BIOTECHNOLOGY MEDIA MARKET SHARES BY REGION, 2010
  • Figure 4 : GLOBAL MARKET FOR SERUM-FREE MEDIA BY REGION, 2009-2016
  • Figure 5 : GLOBAL MARKET FOR SERUM-REQUIRING MEDIA BY REGION, 2009-2016
  • Figure 6 : GLOBAL MARKET FOR POWDERED MEDIA, 2009-2016
  • Figure 7 : GLOBAL MARKET FOR LIQUID MEDIA BY REGION, 2009-2016
  • Figure 8 : GLOBAL MARKET FOR CLASSICAL MEDIA BY REGION, 2009 - 2016
  • Figure 9 : GLOBAL MARKET FOR SPECIALTY MEDIA BY REGION, 2009-2016
  • Figure 10 : GLOBAL MARKET FOR SERA BY REGION, 2009 - 2016
  • Figure 11 : GLOBAL SERA MARKET SHARES BY REGION, 2010
  • Figure 12 : GLOBAL MARKET FOR BOVINE SERA BY REGION, 2009 - 2016
  • Figure 13 : GLOBAL MARKET FOR OTHER SERA BY REGION, 2009-2016
  • Figure 14 : GLOBAL MARKET FOR CELL CULTURE REAGENTS BY REGION, 2009-2016
  • Figure 15 : GLOBAL CELL CULTURE REAGENT MARKET SHARES BY REGION, 2010
  • Figure 16 : GLOBAL MARKET FOR BIOLOGICAL RESPONSE MODIFIERS BY REGION, 2009-2016
  • Figure 17 : GLOBAL MARKET FOR GROWTH FACTORS BY REGION, 2009- 2016
  • Figure 18 : GLOBAL MARKET FOR CYTOKINES BY REGION, 2009-2016
  • Figure 19 : GLOBAL MARKET FOR OTHER BIOLOGICAL RESPONSE MODIFIERS BY REGION, 2009-2016
  • Figure 20 : GLOBAL MARKET FOR CELL DISSOCIATION REAGENTS BY REGION, 2009-2016
  • Figure 21 : GLOBAL MARKET FOR OTHERS BY REGION, 2009-2016
  • Figure 22 : EMERGING MARKETS FOR CELL CULTURE PRODUCTS, 2009-2016
  • Figure 23 : EMERGING MARKETS FOR CELL CULTURE MEDIA, 2009-2016
  • Figure 24 : EMERGING MARKETS FOR SERUM-REQUIRING AND SERUM-FREE MEDIA, THROUGH 2016
  • Figure 25 : EMERGING MARKETS FOR POWDERED AND LIQUID MEDIA, 2009-2016
  • Figure 26 : EMERGING MARKETS FOR CLASSICAL AND SPECIALTY MEDIA, 2009 2016
  • Figure 27 : EMERGING MARKETS FOR BOVINE AND OTHER SERA, 2009-2016
  • Figure 28 : EMERGING MARKETS FOR CELL CULTURE REAGENTS, 2009-2016
  • Figure 29 : EMERGING MARKETS FOR BIOLOGICAL RESPONSE MODIFIERS, 2009-2016
  • Figure 30 : MARKET SHARES OF SERUM FREE MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 31 : MARKET SHARES OF SERUM CONTAINING MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 32 : MARKET SHARES OF POWDERED MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 33 : MARKET SHARES OF LIQUID MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 34 : MARKET SHARES OF CLASSICAL MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 35 : MARKET SHARES OF SPECIALTY MEDIA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 36 : MARKET SHARES OF BOVINE SERA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 37 : MARKET SHARES OF OTHER SERA IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 38 : MARKET SHARES OF BIOLOGICAL RESPONSE MODIFIERS IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 39 : MARKET SHARES OF CELL DISSOCIATION REAGENTS IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 40 : MARKET SHARES OF OTHER REAGENTS IN THE EMERGING MARKETS BY COMPANY, 2010
  • Figure 41 : GLOBAL MEDIA, SERA AND REAGENT MARKET SHARES BY END USER, 2010
  • Figure 42 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE RESEARCH SEGMENT, 2009-2016
  • Figure 43 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE PRODUCTION SEGMENT, 2009-2016
  • Figure 44 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE CONTRACT SEGMENT, 2009-2016
  • Figure 45 : GLOBAL SALES OF MEDIA, SERA AND REAGENTS IN THE OTHERS SEGMENT, 2009-2016
  • Figure 46 : U.S. PATENTS ISSUED BY YEAR, 2007 TO OCT. 2011
  • Figure 47 : PATENTS BY TYPE FOR MEDIA, SERA AND REAGENTS USED IN BIOTECHNOLOGY, 2007 - 2011
Back to Top